Lifecore Biomedical (Lifecore Biomedical) EV-to-EBITDA : -7.74 (As of Apr. 24, 2024)

Lifecore Biomedical EV-to-EBITDA Chart

Lifecore Biomedical Annual Data
	Trend	May14	May15	May16	May17	May18	May19	May20	May21	May22	May23
EV-to-EBITDA		Get a 7-Day Free Trial					18.27	-74.37	-573.27	33.24	-10.16

Lifecore Biomedical Quarterly Data
	Aug18	Nov18	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23
EV-to-EBITDA	Get a 7-Day Free Trial															33.24	49.99	-66.29	-22.12	-10.16

Competitive Comparison of Lifecore Biomedical's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Lifecore Biomedical's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lifecore Biomedical's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Lifecore Biomedical's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Lifecore Biomedical's EV-to-EBITDA falls into.

Lifecore Biomedical EV-to-EBITDA Calculation

Lifecore Biomedical's EV-to-EBITDA for today is calculated as:

Lifecore Biomedical's current Enterprise Value is $290.6 Mil.
Lifecore Biomedical's EBITDA for the trailing twelve months (TTM) ended in May. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-37.5 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lifecore Biomedical  (NAS:LFCR) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Lifecore Biomedical's PE Ratio for today is calculated as:

Lifecore Biomedical's share price for today is $6.33.
Lifecore Biomedical's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in May. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-3.320.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

Lifecore Biomedical EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Lifecore Biomedical's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Lifecore Biomedical (Lifecore Biomedical) Business Description